I found some things quite telling from Clive's discussions on the earnings call this week that are concerning. With the first sign of sales decline following the negative publication on Angiomax in the UK they wasted no time in downsizing the field force there.
And secondly Clive seemed all too willing to answer the question regarding M & A and consolidation. When asked if they are open to approaches to approaches by potential acquirers. " Our website is well known, it has our main headquarters number on it and we are as open as we could possibly be to any phone call from anybody anytime, just make sure it's a highly valuable offering"
If you listen to the archived call it starts at the 01:12:20 mark. My guess is that Shire has it's sights on our company, especially now that the Abbvie deal is off and they received a hefty $ 1.6 billion breakup fee. Our stock price makes us especially vulnerable given it's nearly half of what it was.
And secondly Clive seemed all too willing to answer the question regarding M & A and consolidation. When asked if they are open to approaches to approaches by potential acquirers. " Our website is well known, it has our main headquarters number on it and we are as open as we could possibly be to any phone call from anybody anytime, just make sure it's a highly valuable offering"
If you listen to the archived call it starts at the 01:12:20 mark. My guess is that Shire has it's sights on our company, especially now that the Abbvie deal is off and they received a hefty $ 1.6 billion breakup fee. Our stock price makes us especially vulnerable given it's nearly half of what it was.
Earnings Call
Aucun commentaire:
Enregistrer un commentaire